Correlation Between AVROBIO and ZyVersa Therapeutics
Can any of the company-specific risk be diversified away by investing in both AVROBIO and ZyVersa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AVROBIO and ZyVersa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AVROBIO and ZyVersa Therapeutics, you can compare the effects of market volatilities on AVROBIO and ZyVersa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AVROBIO with a short position of ZyVersa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of AVROBIO and ZyVersa Therapeutics.
Diversification Opportunities for AVROBIO and ZyVersa Therapeutics
-0.65 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between AVROBIO and ZyVersa is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding AVROBIO and ZyVersa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ZyVersa Therapeutics and AVROBIO is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AVROBIO are associated (or correlated) with ZyVersa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ZyVersa Therapeutics has no effect on the direction of AVROBIO i.e., AVROBIO and ZyVersa Therapeutics go up and down completely randomly.
Pair Corralation between AVROBIO and ZyVersa Therapeutics
Given the investment horizon of 90 days AVROBIO is expected to generate 0.24 times more return on investment than ZyVersa Therapeutics. However, AVROBIO is 4.2 times less risky than ZyVersa Therapeutics. It trades about -0.14 of its potential returns per unit of risk. ZyVersa Therapeutics is currently generating about -0.08 per unit of risk. If you would invest 148.00 in AVROBIO on August 24, 2024 and sell it today you would lose (8.00) from holding AVROBIO or give up 5.41% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 14.4% |
| Values | Daily Returns |
AVROBIO vs. ZyVersa Therapeutics
Performance |
| Timeline |
| AVROBIO |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| ZyVersa Therapeutics |
AVROBIO and ZyVersa Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AVROBIO and ZyVersa Therapeutics
The main advantage of trading using opposite AVROBIO and ZyVersa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AVROBIO position performs unexpectedly, ZyVersa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ZyVersa Therapeutics will offset losses from the drop in ZyVersa Therapeutics' long position.| AVROBIO vs. Ocean Biomedical | AVROBIO vs. Enveric Biosciences | AVROBIO vs. Elevation Oncology | AVROBIO vs. Zura Bio Limited |
| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |